Two Sigma Securities’s Lexaria Bioscience Warrant LEXXW Stock Holding History
Bought
Maintained
Sold
Two Sigma Securities's LEXXW Position: Q1 2026 in Review
Two Sigma Securities sold out of Lexaria Bioscience Warrant (LEXXW) in Q1 2026, closing a stake of 22,919 shares — an estimated $96 sold.
Two Sigma Securities first reported a position in LEXXW in Q4 2025 and held it in 1 quarter. The position peaked at $96 in Q4 2025. 0 funds tracked by Wall St. Rank hold LEXXW as of Q1 2026.
- Two Sigma Securities reported no remaining Lexaria Bioscience Warrant position as of Q1 2026 after selling out during the quarter.
- Two Sigma Securities sold 22,919 Lexaria Bioscience Warrant shares in Q1 2026, an estimated $96.
- Two Sigma Securities first reported a position in Lexaria Bioscience Warrant in Q4 2025 and held it in 1 quarter.
- Two Sigma Securities's Lexaria Bioscience Warrant position peaked at $96 in Q4 2025.
- 0 funds tracked by Wall St. Rank held Lexaria Bioscience Warrant as of Q1 2026.
Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.